Daniel Grima

2.2k total citations
67 papers, 1.7k citations indexed

About

Daniel Grima is a scholar working on Economics and Econometrics, Epidemiology and Molecular Biology. According to data from OpenAlex, Daniel Grima has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Economics and Econometrics, 11 papers in Epidemiology and 8 papers in Molecular Biology. Recurrent topics in Daniel Grima's work include Health Systems, Economic Evaluations, Quality of Life (18 papers), Pharmaceutical Economics and Policy (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Daniel Grima is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (18 papers), Pharmaceutical Economics and Policy (7 papers) and Multiple Myeloma Research and Treatments (6 papers). Daniel Grima collaborates with scholars based in Canada, United States and United Kingdom. Daniel Grima's co-authors include Milton C. Weinstein, Thomas C. Wright, Michele Kohli, Eduardo L. Franco, S. J. Goldie, F. Xavier Bosch, Sue J. Goldie, Jonathan D. Adachi, Lisa Bernard and George A. Wells and has published in prestigious journals such as Blood, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Daniel Grima

64 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Grima Canada 18 664 379 268 188 176 67 1.7k
Laura Park‐Wyllie Canada 12 327 0.5× 343 0.9× 218 0.8× 60 0.3× 74 0.4× 33 1.8k
Mitchel J. Seleznick United States 16 537 0.8× 370 1.0× 461 1.7× 33 0.2× 146 0.8× 28 2.3k
Noam Barda Israel 17 302 0.5× 347 0.9× 221 0.8× 124 0.7× 44 0.3× 45 3.7k
Nicholas I. Paton United Kingdom 18 493 0.7× 184 0.5× 93 0.3× 44 0.2× 68 0.4× 39 2.7k
Jacqueline Neuhaus United States 24 981 1.5× 318 0.8× 262 1.0× 30 0.2× 142 0.8× 38 4.2k
Harbir Singh Kohli India 30 504 0.8× 409 1.1× 161 0.6× 57 0.3× 419 2.4× 230 3.3k
Virginia A. Triant United States 28 726 1.1× 684 1.8× 141 0.5× 58 0.3× 180 1.0× 76 4.2k
Stephanie Earnshaw United States 23 362 0.5× 243 0.6× 79 0.3× 394 2.1× 116 0.7× 66 1.4k
Nina Friis‐Møller Denmark 29 1.1k 1.7× 776 2.0× 201 0.8× 41 0.2× 145 0.8× 57 5.9k
Daniel Dedman United Kingdom 16 339 0.5× 207 0.5× 197 0.7× 95 0.5× 48 0.3× 36 1.5k

Countries citing papers authored by Daniel Grima

Since Specialization
Citations

This map shows the geographic impact of Daniel Grima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Grima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Grima more than expected).

Fields of papers citing papers by Daniel Grima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Grima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Grima. The network helps show where Daniel Grima may publish in the future.

Co-authorship network of co-authors of Daniel Grima

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Grima. A scholar is included among the top collaborators of Daniel Grima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Grima. Daniel Grima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Baharnoori, Moogeh, Virender Bhan, Kimberly Thomas, et al.. (2022). Cost-Effectiveness Analysis of Ofatumumab for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada. PharmacoEconomics - Open. 6(6). 859–870. 16 indexed citations
3.
Gupta, Dhiraj, Tom De Potter, Tim Disher, et al.. (2020). Comparative effectiveness of catheter ablation devices in the treatment of atrial fibrillation: a network meta-analysis. Journal of Comparative Effectiveness Research. 9(2). 115–126. 10 indexed citations
4.
Evans, William K., Parneet Cheema, Randeep Sangha, et al.. (2019). Development, validation and results from the impact of treatment evolution in non-small cell lung cancer (iTEN) model. Lung Cancer. 139. 185–194. 11 indexed citations
5.
6.
7.
Grima, Daniel, et al.. (2014). Insights Into the Pan-Canadian Oncology Drug Revew Recommendations - Three Years After its Inception. Value in Health. 17(3). A100–A100. 2 indexed citations
8.
9.
10.
11.
Grima, Daniel, et al.. (2013). Comparison Of Cancer Therapy Reimbursement Decisions Made In Canada To Australia, Sweden And The United Kingdom. Value in Health. 16(3). A153–A153. 1 indexed citations
12.
13.
14.
Grima, Daniel, et al.. (2010). Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney. Current Medical Research and Opinion. 27(2). 383–391. 10 indexed citations
15.
16.
Grima, Daniel, et al.. (2006). Considerations in Developing Model-based Economic Evaluations of Glaucoma Treatment. Journal of Glaucoma. 15(6). 541–547. 1 indexed citations
17.
Goldie, Sue J., Daniel Grima, Michele Kohli, et al.. (2003). A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine. International Journal of Cancer. 106(6). 896–904. 171 indexed citations
18.
Tosteson, Anna N.A., Bengt Jönsson, Daniel Grima, et al.. (2001). Challenges for Model-Based Economic Evaluations of Postmenopausal Osteoporosis Interventions. Osteoporosis International. 12(10). 849–857. 85 indexed citations
19.
Grima, Daniel, George W. Torrance, Cathy J. Bradley, et al.. (1998). Cost Effectiveness of Multi-Therapy Treatment Strategies in the Prevention of Vertebral Fractures in Postmenopausal Women with Osteoporosis. PharmacoEconomics. 14(5). 559–573. 28 indexed citations
20.
Grima, Daniel, et al.. (1996). The total process cost of parenteral antibiotic therapy: beyond drug acquisition cost. Clinical Therapeutics. 18(4). 716–725. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Park‐Wyllie Breakdown of academic impact, for papers by Mitchel J. Seleznick Breakdown of academic impact, for papers by Noam Barda Breakdown of academic impact, for papers by Nicholas I. Paton Breakdown of academic impact, for papers by Jacqueline Neuhaus Breakdown of academic impact, for papers by Harbir Singh Kohli Breakdown of academic impact, for papers by Virginia A. Triant Breakdown of academic impact, for papers by Stephanie Earnshaw Breakdown of academic impact, for papers by Nina Friis‐Møller Breakdown of academic impact, for papers by Daniel Dedman
Rankless by CCL
2026